RAGE Genetic Polymorphisms Are Associated with Risk, Chemotherapy Response and Prognosis in Patients with Advanced NSCLC

AIM: To explore the association between genetic polymorphisms of the receptor for advanced glycation end-products (RAGE) and susceptibility, chemotherapy response rate and prognosis of non-small cell lung cancer (NSCLC). METHOD: This is a prospective study in which 562 patients with NSCLC and 764 he...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiang, Cui, Enhai, Zeng, Huazong, Hua, Feng, Wang, Bin, Mao, Wei, Feng, Xueren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465300/
https://www.ncbi.nlm.nih.gov/pubmed/23071492
http://dx.doi.org/10.1371/journal.pone.0043734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465300/
https://www.ncbi.nlm.nih.gov/pubmed/23071492
http://dx.doi.org/10.1371/journal.pone.0043734

Ejemplares similares